Gene plays a role in breast cancer's response to estrogen

09/17/2007 | Yahoo!

Transcription factor AP2C controls multiple pathways of estrogen signaling, a U.S. study revealed. Researchers also found that silencing the gene restricted tumor growth in mice and stopped the expression of the GPR30 estrogen receptor. They hope the finding may lead to development of drugs for hormone-responsive breast cancers.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC